Detalles de la búsqueda
1.
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03).
Breast Cancer Res Treat
; 169(3): 537-548, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29455298
2.
Long-term follow-up of chemoimmunotherapy with rituximab, oxaliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B-cell non-Hodgkin lymphoma: Results of a study of the Mayo Clinic Cancer Center Research Consortium (MCCRC) MC0485 now known as academic and community cancer research united (ACCRU).
Am J Hematol
; 92(10): 1004-1010, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28614905
3.
Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.
Am J Hematol
; 92(8): 759-763, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28402581
4.
A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy-associated anemia.
Am J Hematol
; 90(10): 877-81, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26149465
5.
Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma.
Blood
; 118(15): 4053-61, 2011 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-21673350
6.
The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9.
Support Care Cancer
; 21(4): 1185-92, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23150188
7.
Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance]).
Eur J Cancer
; 150: 214-223, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33934058
8.
Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation.
Biol Blood Marrow Transplant
; 16(8): 1107-14, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20188202
9.
Does sunscreen prevent epidermal growth factor receptor (EGFR) inhibitor-induced rash? Results of a placebo-controlled trial from the North Central Cancer Treatment Group (N05C4).
Oncologist
; 15(9): 1016-22, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20798191
10.
Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM.
J Neurooncol
; 99(1): 73-80, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20063115
11.
Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC.
Breast Cancer Res Treat
; 117(3): 603-9, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19214743
12.
Long-term survivors of metastatic colorectal cancer treated with systemic chemotherapy alone: a North Central Cancer Treatment Group review of 3811 patients, N0144.
Clin Colorectal Cancer
; 8(2): 88-93, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19739269
13.
Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results.
J Neurooncol
; 92(2): 165-75, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19066728
14.
Improving Rural Clinical Trial Enrollment: Recommendations From the Rural Health Working Group of the Alliance Clinical Trials Network.
J Clin Oncol
; 42(14): 1722-1725, 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38412385
15.
Interleukin-1 genetic polymorphisms and their relationship to the cancer anorexia/weight loss syndrome in metastatic gastric and gastroesophageal junction adenocarcinoma.
J Support Oncol
; 5(1): 41-6, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17265786
16.
Randomized phase II trial of three schedules of pemetrexed and gemcitabine as front-line therapy for advanced non-small-cell lung cancer.
J Clin Oncol
; 23(25): 5929-37, 2005 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16135464
17.
A randomized phase II trial comparing chemoimmunotherapy with or without bevacizumab in previously untreated patients with chronic lymphocytic leukemia.
Oncotarget
; 7(48): 78269-78280, 2016 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-27861157
18.
A Phase II trial of docetaxel and carboplatin administered every 2 weeks as preoperative therapy for stage II or III breast cancer: NCCTG study N0338.
Am J Clin Oncol
; 36(6): 540-4, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22868240
19.
Association of obesity with DNA mismatch repair status and clinical outcome in patients with stage II or III colon carcinoma participating in NCCTG and NSABP adjuvant chemotherapy trials.
J Clin Oncol
; 30(4): 406-12, 2012 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22203756
20.
North central cancer treatment group (NCCTG) N0537: phase II trial of VEGF-trap in patients with metastatic breast cancer previously treated with an anthracycline and/or a taxane.
Clin Breast Cancer
; 12(6): 387-91, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23083501